Literature DB >> 7020047

Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae.

C J Lee, B A Fraser, S Szu, K T Lin.   

Abstract

By use of rabbit antisera, extensive cross-reactions were demonstrated among pneumococcal (Danish) types 6A and 6B, types 9N, 9A, 9L, and 9V, and types 19F and 19A. The structural similarity of the group 6 polysaccharides was associated with extensive immunogenicity in humans. In contrast, immunization of humans with type 19F or 19A may not induce sufficient cross-protection. The type 19F polysaccharide has the structure of a linear polymer of N-acetylmannosamine-glucose-rhamnose phosphate. Danish type 19A (type 57 in the United States system) polysaccharide contains this repeating unit and, in addition, has side chains of N-acetylglucosamine-galactose phosphate and fucose phosphate. Maternal immunization with type 19F or type 6A polysaccharide during pregnancy elicited high antibody formation in the offspring. Young mice, which received an additional dose of polysaccharide at two weeks of age, showed a higher antibody response than did those that did not receive polysaccharide. These studies reveal that the extensive cross-immunogenicity of pneumococcal group polysaccharides has a basis in chemical structure. Maternal immunization with pneumococcal polysaccharides may enhance the immune response of neonates.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020047     DOI: 10.1093/clinids/3.2.323

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  6 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

Review 2.  Current Development of Nano-Drug Delivery to Target Macrophages.

Authors:  Donglin Cai; Wendong Gao; Zhelun Li; Yufeng Zhang; Lan Xiao; Yin Xiao
Journal:  Biomedicines       Date:  2022-05-23

3.  Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.

Authors:  J H Braconier; E B Myhre; H Odeberg
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

4.  Immune response of neonates to pneumococcal polysaccharide-protein conjugate.

Authors:  K T Lin; C J Lee
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

Review 5.  Bacteria-Inspired Nanomedicine.

Authors:  Maya Holay; Zhongyuan Guo; Jessica Pihl; Jiyoung Heo; Joon Ho Park; Ronnie H Fang; Liangfang Zhang
Journal:  ACS Appl Bio Mater       Date:  2020-10-08

6.  Liposomal co-entrapment of CD40mAb induces enhanced IgG responses against bacterial polysaccharide and protein.

Authors:  Caterina Hatzifoti; Andrew Bacon; Helen Marriott; Peter Laing; Andrew W Heath
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.